2012. ISCB Annual Conference – Analysis of time to patient-reported outcome meaningful change: Illustration from a clinical trial of catumaxomab in patients with malignant ascites

 

Gilet H, Regnault A. Analysis of time to patient-reported outcome meaningful change: Illustration from a clinical trial of catumaxomab in patients with malignant ascites. Abstract P10.2. Presented at: International Society for Clinical Biostatistics (ISCB) 33rd Annual Conference; August 19, 2012; Bergen, Norway.